239 related articles for article (PubMed ID: 30088779)
21. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
[TBL] [Abstract][Full Text] [Related]
22. Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation.
Snyder LD; Chan C; Kwon D; Yi JS; Martissa JA; Copeland CA; Osborne RJ; Sparks SD; Palmer SM; Weinhold KJ
Am J Respir Crit Care Med; 2016 Jan; 193(1):78-85. PubMed ID: 26372850
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.
Iasella CJ; Winters SA; Kois A; Cho J; Hannan SJ; Koshy R; Moore CA; Ensor CR; Lendermon EA; Morrell MR; Pilewski JM; Sanchez PG; Kass DJ; Alder JK; Nouraie SM; McDyer JF
Am J Transplant; 2020 May; 20(5):1439-1446. PubMed ID: 31874120
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults.
Riddell NE; Griffiths SJ; Rivino L; King DC; Teo GH; Henson SM; Cantisan S; Solana R; Kemeny DM; MacAry PA; Larbi A; Akbar AN
Immunology; 2015 Apr; 144(4):549-60. PubMed ID: 25314332
[TBL] [Abstract][Full Text] [Related]
25. High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control.
Akulian JA; Pipeling MR; John ER; Orens JB; Lechtzin N; McDyer JF
Am J Transplant; 2013 Jan; 13(1):146-56. PubMed ID: 23016698
[TBL] [Abstract][Full Text] [Related]
26. High incidence of clinically significant cytomegalovirus infection in CMV D+/R+ lung transplant recipients receiving 3 months of antiviral prophylaxis.
Kabbani D; Hirji A; Hernandez C; Malhi H; Mabilangan C; Chandrarathne S; Halloran K; Weinkauf J; Kapasi A; Lien D; Preiksaitis J; Cervera C
Transpl Infect Dis; 2019 Aug; 21(4):e13094. PubMed ID: 30985048
[TBL] [Abstract][Full Text] [Related]
27. Association of human cytomegalovirus DNAaemia and specific granzyme B responses in lung transplant recipients.
Weseslindtner L; Kerschner H; Steinacher D; Kundi M; Jaksch P; Simon B; Hatos-Agyi L; Scheed A; Klepetko W; Puchhammer-Stöckl E
Clin Exp Immunol; 2013 Sep; 173(3):438-43. PubMed ID: 23607435
[TBL] [Abstract][Full Text] [Related]
28. Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.
Smith C; Brennan RM; Tey SK; Smyth MJ; Burrows SR; Miles JJ; Hill GR; Khanna R
J Virol; 2016 Aug; 90(16):7497-507. PubMed ID: 27279616
[TBL] [Abstract][Full Text] [Related]
29. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
[TBL] [Abstract][Full Text] [Related]
30. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus replication is associated with enrichment of distinct γδ T cell subsets following lung transplantation: A novel therapeutic approach?
Stankovic S; Davey MS; Shaw EM; von Borstel A; Cristiano Y; Levvey BJ; Rossjohn J; Westall GP; Snell GI; Brooks AG; Sullivan LC
J Heart Lung Transplant; 2020 Nov; 39(11):1300-1312. PubMed ID: 32962919
[TBL] [Abstract][Full Text] [Related]
32. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
[TBL] [Abstract][Full Text] [Related]
33. Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice.
Solidoro P; Patrucco F; Boffini M; Rinaldi M; Airoldi C; Costa C; Cavallo R; Albera C
Ther Adv Respir Dis; 2020; 14():1753466620981851. PubMed ID: 33356914
[TBL] [Abstract][Full Text] [Related]
34. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis.
Solidoro P; Patrucco F; Libertucci D; Verri G; Sidoti F; Curtoni A; Boffini M; Simonato E; Rinaldi M; Cavallo R; Costa C
Ther Adv Respir Dis; 2019; 13():1753466619878555. PubMed ID: 31566097
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study.
Chanouzas D; Small A; Borrows R; Ball S
PLoS One; 2018; 13(3):e0193968. PubMed ID: 29558479
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G
J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105
[TBL] [Abstract][Full Text] [Related]
37. CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.
Mena-Romo JD; Pérez Romero P; Martín-Gandul C; Gentil MÁ; Suárez-Artacho G; Lage E; Sánchez M; Cordero E
J Infect; 2017 Oct; 75(4):336-345. PubMed ID: 28599954
[TBL] [Abstract][Full Text] [Related]
38. Where the Chromosome Ends: Telomeres and Cytomegalovirus Risk in Lung Transplant Recipients.
Greenland JR
Am J Respir Crit Care Med; 2019 Feb; 199(3):265-267. PubMed ID: 30160976
[No Abstract] [Full Text] [Related]
39. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
40. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
